RN7SL665P

Across TCGA pan-cancer cohorts, RN7SL665P RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of RN7SL665P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where RN7SL665P RNA is repressed in tumor relative to normal tissue. In most cancer types RN7SL665P is over-expressed in tumor, although a few such as KIRP and READ show the opposite, repressed pattern.

KIRP, UCEC, and READ are the cancer types where RN7SL665P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL665P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	Male	III,IV	−0.188	.007	4	view →
UCEC	All	All	+0.145	.011	4	view →
READ	Female	All	−0.308	.005	2	view →
LIHC	Male	III,IV	+0.187	.011	2	view →
KIRC	All	II,III,IV	+0.090	.019	2	view →
STAD	Male	IV	−0.990	.009	1	view →
LUAD	All	All	+0.378	.044	1	view →
COAD	Female	All	−0.169	.021	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

RN7SL665P–KIRP

Open the KIRP breakdown →